Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kaski, J.C.
Right arrow Articles by Zouridakis, E.G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kaski, J.C.
Right arrow Articles by Zouridakis, E.G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Inflammation, infection and acute coronary plaque events

J.C. Kaski* and E.G. Zouridakis

Coronary Artery Disease Research Unit, Cardiological Sciences, St. George's Hospital Medical School, London, U.K.

* Correspondence: Professor Juan Carlos Kaski, MD, FRCP, FESC, FACC, Coronary Artery Disease Research Unit, Cardiological Sciences, St. George's Hospital Medical School, Cranmer Terrace, London SW17 0RE, U.K.

Abstract

Aims In recent years it has become apparent that inflammatory and immune mechanisms are involved not only in the initiation and progression of atherosclerosis but also in the pathophysiology of atheromatous plaque disruption and the development of acute coronary syndromes. Fissuring and rupture of the fibrous cap that overlies the lipid-rich core of an atherosclerotic lesion has been recognized as the most common cause of acute coronary thrombosis and acute coronary events. Hence, the integrity of the fibrous cap is a crucial determinant of plaque stability.

Methods and results This overview examines inflammatory and infectious factors that affect the integrity of the fibrous cap and hence the likelihood of acute coronary plaque events. Inflammatory cells such as activated macrophages within atherosclerotic lesions can express metalloproteinases — enzymes responsible for the degradation of collagen in the fibrous cap — while activated lymphocytes can suppress collagen synthesis. The result is a weakening of the fibrous cap, which can lead to the transformation of a lesion from ‘stable’ to ‘unstable’, and hence prone to rupture and thrombosis. Pro- and anti inflammatory cytokines control the complex interactions that take place between the different components of the inflammatory process. A number of recent studies have also provided increasing evidence that chronic infections by bacteria or viruses may play a contributory role in the inflammation that underlies active atherosclerotic lesions and the development of acute coronary syndromes.

Conclusion Despite the recognition of the major role of inflammation in atherogenesis and acute plaque events, the effects of anti-inflammatory treatments in primary and secondary prevention are still largely unknown. The emergence of novel agents with both anti-inflammatory and anti-platelet properties may help in the future to reduce the incidence of serious coronary events in high-risk patients.

Key Words: Acute coronary syndromes • atherosclerosis • anti-inflammatory • anti-platelet • unstable atheromatous plaques


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.